Table:
begin	end	state
1	11	cytoplasmic
12	31	transmembrane
32	42	non-cytoplasmic
43	62	transmembrane
63	94	cytoplasmic
95	120	transmembrane
121	127	non-cytoplasmic
128	149	transmembrane
150	157	cytoplasmic
158	180	transmembrane
181	208	non-cytoplasmic
209	228	transmembrane
229	239	cytoplasmic
240	262	transmembrane
263	283	non-cytoplasmic
284	309	transmembrane
310	337	cytoplasmic
338	357	transmembrane
358	362	non-cytoplasmic
363	387	transmembrane
388	399	cytoplasmic
400	417	transmembrane
418	422	non-cytoplasmic
423	441	transmembrane
442	452	cytoplasmic
453	473	transmembrane
474	480	non-cytoplasmic

Input:
>AZOBR_RS13260
VAQTRKSDKLTLLPLVALVVGSMIGGGVFNLPSDMSKGASPGAILIGWMITGIGMMMLAF
VYQNLAVRKPNLNAGPYAYAKAGFGPFVGFNSAWGYWLSAFLGNVAYAVAIFSALSHFFP
IFGDGNNLPSIVGASLCLWLIHALVLSGIKQAAFVNVVTSIAKLVPLFLFVLVAIVGFHW
DRFTVDFWGTGAGSGTGGLGSVMEQVKSTMLVTLWVFIGIEGASVYSARAARRSDVGRAT
VIGFVGALGIYVLVSLLATGVLRQPELADLKVPSMAGVFESLVGPWGAALINIGLVISVG
GAFLSWTLLCAEIPYTCGRDGTFPKWFAAENANGSPVNALWATNLLIQLFLALSFFSRSA
YQFFYFIASVAILPPYVLSGAYALKLALTGEGYGAESRTKGILVGALATAYGLWLVYAAG
LQYLLMCAVLFAPGILVYVRARREHGERTFTGVEMAIAAAIAVLAVLAAWLMWTGRISPL

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server